Critics argue that the French government should intervene to prevent the sale of Sanofi’s Doliprane painkiller to U.S. private equity
French drugmaker Sanofi’s announcement that it will sell a majority stake in its consumer health division to a US investment fund has sparked a new wave of political backlash, with concerns about the loss of control over essential medications. Paris is being urged to block the sale by using its powers to safeguard strategic sectors, … Read more